36.6 F
New York
Thursday, April 22, 2021

Eli Lilly [NYSE: LLY] Seeks FDA Emergency Use Authorization For COVID-19 Antibody Therapy

Must read

Palantir [NYSE: PLTR] Recognized as a Crown Commercial Service supplier

Palantir Technologies Inc. has gained recognition as a supplier on the Crown Commercial Service (CCS) Back Office Software (BOS) RM6194 Framework. This award...

Trevena [NASDAQ: TRVN] Soar on Selection of TRV027in Global COVID-19 Trial

Shares of Trevena, Inc. skyrocketed more than 5 percent during the pre-market trading session of Wednesday. The strong performance of the firm indicated...

InfuSystem Announces Acquisition of OB Healthcare Corporation

InfuSystem Holdings Inc. disclosed Wednesday that it has bought OB Healthcare Corporation. As per the acquisition agreement, the firm has purchased the operating...

IAA [NYSE: IAA] Announces Expansion of Delivery Services in the UK

IAA, Inc. disclosed that its UK-based business unit has decided to expand its vehicle delivery services for its buyers. This expansion decision has...

Eli Lilly and Company [NYSE: LLY] disclosed Wednesday that it has submitted an application to the FDA for the emergency use authorization of COVID-19 monoclonal antibody treatment.

Emergency Use Authorization (EUA) is not a complete approval but it is a sort of regulatory authorization to accelerate the process of bringing new therapies to the market.

Eli Lilly has earlier disclosed that the self-governing candidate, LY-CoV555, has shown a promising result in the clinical trial. The drug candidate has reduced the rate of hospitalization.

Vaccine candidate has also shown the encouraging results as it reduced the viral infection in some mild to moderately ill COVID-19 patients.

Eli Lilly and Company [NYSE: LLY] shares traded up 2.97% during the trading session of Wednesday. It has a closing price of $148.41. The drug manufacturing company had a trading volume of 171.36K as compared to the average volume of 3.08 Million.

This company stock has changed between the 52-weeks low range of $101.36 and a high range of $170.75. It has moved up 46.42% from its 52-weeks low and moved down -13.08% from its 52-weeks high.

Looking at its liquidity, it has a current ratio of 1.20. This company market capitaliztaion has remained high, hitting $136.98 billion at the time of writing.

Eli Lilly revealed that it has the capability to produce the one million doses of monotherapy in the Q4. The company has shared the Phase II clinical results of LY-CoV555 and LY-CoV016, another antibody-based therapy, in 268 patients. 

It has reported encouraging results as the candidates are proven to be useful in reducing the viral infection in patients.

More articles

Latest article

ICON [NASDAQ: ICLR] Secures Multiple Categories in 2021 CRO Leadership Awards

ICON Public Limited Company has disclosed that it has won multiple categories in the annual CRO Leadership Awards. This is another greatest achievement...

Equinox Announces Sale of Pilar Gold Mine

Equinox Gold Corp. revealed Monday that it has decided to sell its Pilar Gold Mine in Brazil to Pilar Gold Inc. The firm...

OpGen [NASDAQ: OPGN] Announces Strategic Collaboration New York State Department of Health

OpGen, Inc. revealed that it has entered into a strategic collaboration deal with the New York State Department of Health. The focus of...

Why Mer Telemanagement [NASDAQ: MTSL] Skyrocketed on Friday?

Shares of Mer Telemanagement Solutions Ltd skyrocketed during the trading session of Friday. The strong performance of the firm has indicated the positive...

Largo Resources Gets Approval for Listing on Nasdaq Stock Exchange

Largo Resources disclosed that it has finally obtained authorization from Nasdaq Stock Market LLC. As per the approval, the firm will now eligible to...

Aurora Mobile [NASDAQ: JG] Inks Agreement with Wanda Film

Aurora Mobile Limited disclosed Thursday that it has inked an agreement with Wanda Film Holding Co Ltd. Since its inception, Aurora Mobile has...

Brady [NYSE: BRC] Commence Tender Offer to Buy Nordic ID Oyj

Brady Corporation has inked an agreement with Nordic ID for its acquisition. The firm has commenced the tender offering to buy all the...

Cinedigm [NASDAQ: CIDM] Achieve Record Subscription and Ad-Supported User Growth Milestones

Shares of Cinedigm Corp. skyrocketed 19.30% after the firm reported the update about the subscription. The firm has achieved the best ever achievement...